US OptionsDetailed Quotes
SIGA250117C19000
- 0.00
- 0.000.00%
15min DelayClose Jan 2 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest19.00Strike Price0.00Turnover0.00%IV204.49%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier15DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.90Leverage Ratio--Theta--Rho--Eff Leverage--Vega
SIGA Technologies Stock Discussion
Tepoxx (Tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses
Wow almost bought in too...
SIGA Technologies (SIGA) Shares Tumble After Mpox Therapy Fails, Chief Medical Officer Terminated - Hagens Berman
phew
SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies
SIGA Technologies (NASDAQ: SIGA) has entered into an exclusive license agreement with Vanderbilt University for a portfolio of preclinical fully human monoclonal antibodies (mAbs). These mAbs have potential as treatments for a broad range of orthopoxviruses, including smallpox and mpox. The agreement grants SIGA exclusive rights to develop, manufacture...
SIGA Technologies Inc - Contract in Response to Morocco Ministry of Health Request. Makes first commercial sale in Africa
SIGA Announces Agreement to Supply TPOXX® in Morocco
wow, finally increasing a little... wondering if it's best to wait for before earnings report to buy in
No comment yet